Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Contracts Finder |
| Notice Type: | Award notice |
| Buyer: | London School of Hygiene & Tropical Medicine |
| Main Category: | Goods |
| Procurement Method: | Open procedure |
| Tender Status: | Closed |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
5 January 2022
Closed
Estimated Value
£900,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Estimated Value (ex. VAT): |
| £900,000 |
| Release Date: | 21 August 2023 |
| Application Deadline: | 5 January 2022 |
| Contract Start Date: | 9 August 2023 |
| Contract End Date: | 31 August 2025 |
| Contract Duration: | 2.1 years |
| Procurement ID (OCID): | ocds-b5fd17-5d20a6df-308a-46fa-beca-e486f33eeffa |
| Notice Reference: | 64f128db-8318-4633-9c60-3f438402ca2a-673857 |
View Original Notice
Access the full notice on the official portal
Awarded to
| Award value: | £1,066,444 |
| Award decision date: | 9 August 2023 |
| Award status: | Active |
Manufacturing and packing of IMP for the IM Woman Trial due to commence in March 2023. A randomised, triple-blind, three-arm, non-inferiority trial to assess the efficacy and safety of intramuscular tranexamic acid compared to intravenous tranexamic acid and placebo in women having vvaginal and caesarean section births. Three arms include experimental treatment (IM TXA), reference treatment/active control (IV TXA), and placebo control (0.9% sodium chloride solution). Provision of treatment kit boxes required for 4 campaigns with approximately 10,000 patient packs per campaign. Recruitment period is 24 months - campaign approximately once every 6 months commencing March 2023.
Published contracts in the last 12 months
40
total contracts
£77.5m
total value
£4,844,250
average contract size
Typical categories